InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Baskies Arnold M, Director. Insider active across 2 companies, notably Baudax Bio, Inc.. Aggregated, 10 disclosures have been logged. Breakdown: 9 buys · 0 sell. Total volume traded: €346k. Activity tracked since 11 May 2021. The latest transaction was filed on 28 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
5,000 shares@ US$2.824.1% of flowCommon StockSEC:0001493152-25-004108:0
Ideal exit: 25 Oct 2025 (T+270)
5,000 shares@ US$3.094.3% of flowCommon StockSEC:0001493152-24-029191:0
Ideal exit: 22 Apr 2025 (T+270)
10,000 shares@ US$3.6310.0% of flowCommon StockSEC:0001493152-24-010060:0
Ideal exit: 10 Dec 2024 (T+270)
39,473 shares0Common StockSEC:0001062993-22-015132:0
19,000 shares@ US$4.3321.0% of flowCommon StockSEC:0001493152-21-017817
Ideal exit: 19 Apr 2022 (T+270)
19,000 shares@ US$4.330.074% mcap25.7% of flowCommon StockSEC:0001493152-21-017817:0
Ideal exit: 19 Apr 2022 (T+270)
20,000 shares@ US$3.9019.8% of flowCommon StockSEC:0001493152-21-017005
Ideal exit: 11 Apr 2022 (T+270)
20,000 shares@ US$3.900.070% mcap24.3% of flowCommon StockSEC:0001493152-21-017005:0
Ideal exit: 11 Apr 2022 (T+270)
10,000 shares@ US$0.8250.0% of flowCommon StockSEC:0001192482-21-000422
Ideal exit: 5 Feb 2022 (T+270)
10,000 shares@ US$0.8250.0% of flowCommon StockSEC:0001192482-21-000422:0
Ideal exit: 5 Feb 2022 (T+270)
10 of 10 declarations
About Baskies Arnold M
Arnold M Baskies serves as a Board Member at Baudax Bio, Inc. and Anixa Biosciences Inc. He contributes to the governance and strategy of these firms. His experience in the biopharmaceutical sector is valuable for guiding strategic decisions and promoting innovation in the development of new treatments.
